The Food and Drug Administration issued guidance expanding the use of telethermographic systems for triage use during the public health crisis. Because fever is a common symptom of the virus, FDA says that telethermographic systems, which convert infrared radiation into body temperature measurement, can be deployed to use for initial triage at high-traffic areas, such as airports, businesses, warehouses and factories, as well as in settings where thermometers may be in short supply.

Related News Articles

Headline
The Department of Health and Human Services yesterday released initial data on how states and territories plan to use their share of 100 million rapid point-of…
Headline
According to an analysis of COVID-19 hospitalization data from 13 states, released today by the Centers for Disease Control and Prevention, 6% of adults…
Headline
The Food and Drug Administration yesterday approved Veklury (remdesivir) to treat COVID-19 patients age 12 and older who are hospitalized and weigh…
Headline
To continue amplifying the important message of protecting against both the flu and COVID-19, AHA’s United Against the Flu campaign today released new…
Perspective
A COVID-19 vaccine is likely coming soon. Whether it’s next month, at the end of the year or in early 2021, many scientific experts believe we will have one or…
Headline
Three leadership capabilities consistently rise to the top when Andy Shin, chief operating officer for the AHA’s Center for Health Innovation, interviews…